“Impact of Baseline Smoking Status and Body Mass Index in Patients with Hidradenitis Suppurativa Treated with Adalimumab or Placebo in Phase 2 or 3 Studies”, J of Skin, vol. 1, no. 3.1, p. s130, Oct. 2017, doi: 10.25251/skin.1.supp.129.